An innovative cellular medicine approach via the utilization of novel nanotechnology-based biomechatronic platforms as a label-free biomarker for early melanoma diagnosis.
- DOI
- 10.1038/s41598-024-79154-z
- Published
- 2024 Dec 3
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-024-79154-z,
title = {An innovative cellular medicine approach via the utilization of novel nanotechnology-based biomechatronic platforms as a label-free biomarker for early melanoma diagnosis.},
author = {Alqabandi JA and David R and Abdel-Motal UM and ElAbd RO and Youcef-Toumi K},
year = {2024},
journal = {Scientific reports},
doi = {10.1038/s41598-024-79154-z},
url = {https://doi.org/10.1038/s41598-024-79154-z}
}RIS
TY - JOUR TI - An innovative cellular medicine approach via the utilization of novel nanotechnology-based biomechatronic platforms as a label-free biomarker for early melanoma diagnosis. AU - Alqabandi JA AU - David R AU - Abdel-Motal UM AU - ElAbd RO AU - Youcef-Toumi K PY - 2024 JO - Scientific reports DO - 10.1038/s41598-024-79154-z UR - https://doi.org/10.1038/s41598-024-79154-z ER -
APA
JA, A., R, D., UM, A., RO, E., & K, Y. (2024). An innovative cellular medicine approach via the utilization of novel nanotechnology-based biomechatronic platforms as a label-free biomarker for early melanoma diagnosis.. Scientific reports. https://doi.org/10.1038/s41598-024-79154-z
Source records
- pubmed · retrieved 2026-09-25T21:03:39.239Z
- europe-pmc · retrieved 2026-09-25T21:03:39.257Z
- doaj · retrieved 2026-09-25T21:03:39.279Z